nach oben

Erschienen in:

26.03.2019

Exploring the structural similarity yet functional distinction between coagulation factor XIII-B and complement factor H sushi domains

verfasst von: Mohammad Suhail Akhter, Sneha Singh, Hamideh Yadegari, Vytautas Ivaskevicius, Johannes Oldenburg, Arijit Biswas

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Coagulation factor XIII (FXIII) covalently crosslinks pre-formed fibrin clots preventing their premature fibrinolysis. In plasma, FXIII circulates as a zymogenic heterotetramer composed of catalytic FXIII-A subunits, and carrier/regulatory FXIII-B subunits. FXIII-A is a well characterized component of this complex, and has been associated with several pleiotropic roles outside coagulation as well. In comparison only protective/regulatory roles towards the FXIII-A subunit have been identified for FXIII-B. Strong homology between FXIII-B and complement regulator Complement factor H suggests a putative role of FXIII-B in complement activation. In the current study we have analyzed the similarities and yet functional divergence of these two proteins using in silico sequence alignment and structural analysis. We have evaluated complement activation post reconstitution of FXIII components into FXIII deficient and CFH deficient plasma. We have also transiently expressed FXIII-B in SH-SY5Y cell lines and evaluated its effect on the endogenous complement activation. Our investigations show no effect of FXIII-B subunit on the rate of complement activation. Therefore we conclude that at a physiological level, FXIII-B subunit plays no role in the complement system, although a vestigial function in altered pathological states might still exist.

Nur mit Berechtigung zugänglich

Amara U, Flierl MA, Rittirsch D et al (2010) Molecular intercommunication between the complement and coagulation systems. J Immunol 185(9):5628–5636. https://doi.org/10.4049/jimmunol.0903678 CrossRefPubMed

Esmon CT (2004) The impact of the inflammatory response on coagulation. Thromb Res 114(5–6):321–327. https://doi.org/10.1016/j.thromres.2004.06.028 CrossRefPubMed

Krisinger MJ, Goebeler V, Lu Z et al (2012) Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway. Blood 120(8):1717–1725. https://doi.org/10.1182/blood-2012-02-412080 CrossRefPubMed

Foley JH, Walton BL, Aleman MM et al (2016) Complement activation in arterial and venous thrombosis is mediated by plasmin. EBioMedicine 5:175–182. https://doi.org/10.1016/j.ebiom.2016.02.011 CrossRefPubMedPubMedCentral

Markiewski MM, DeAngelis RA, Lambris JD (2008) Complexity of complement activation in sepsis. J Cell Mol Med 12(6a):2245–2254. https://doi.org/10.1111/j.1582-4934.2008.00504.x CrossRefPubMedPubMedCentral

Jenny L, Dobó J, Gál P et al (2018) MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model. PLoS ONE 13(1):e0191292. https://doi.org/10.1371/journal.pone.0191292 CrossRefPubMedPubMedCentral

Adamiak M, Abdelbaset-Ismail A, Suszynska M et al (2017) Novel evidence that the mannan-binding lectin pathway of complement activation plays a pivotal role in triggering mobilization of hematopoietic stem/progenitor cells by activation of both the complement and coagulation cascades. Leukemia 31(1):262–265. https://doi.org/10.1038/leu.2016.278 CrossRefPubMed

Gupta S, Biswas A, Akhter MS et al (2016) Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective. Sci Rep 6(1):245. https://doi.org/10.1038/srep30105 CrossRef

Biswas A, Thomas A, Bevans CG et al (2013) In vitro secretion deficits are common among human coagulation factor XIII subunit B missense mutants. Correlations with patient phenotypes and molecular models. Human Mutation 34(11):1490–1500. https://doi.org/10.1002/humu.22391 CrossRefPubMed

10.

Thomas A, Biswas A, Ivaskevicius V et al (2015) Structural and functional influences of coagulation factor XIII subunit B heterozygous missense mutants. Mol Genet Genomic Med 3(4):258–271. https://doi.org/10.1002/mgg3.138 CrossRefPubMedPubMedCentral

11.

Schroeder V, Kohler H (2016) Factor XIII: structure and function. Semin Thromb Hemost 42(04):422–428. https://doi.org/10.1055/s-0036-1571341 CrossRefPubMed

12.

Souri M, Kaetsu H, Ichinose A (2008) Sushi domains in the B subunit of factor XIII responsible for oligomer assembly. Biochemistry 47(33):8656–8664. https://doi.org/10.1021/bi8006143 CrossRefPubMed

13.

Mezei ZA, Katona É, Kállai J et al (2017) Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism. Thromb Res 158:93–97. https://doi.org/10.1016/j.thromres.2017.08.018 CrossRefPubMed

14.

Pitkänen HH, Jouppila A, Lemponen M et al (2017) Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement. Thromb Res 149:56–61. https://doi.org/10.1016/j.thromres.2016.11.012 CrossRefPubMed

15.

Deicke C, Chakrakodi B, Pils MC et al (2016) Local activation of coagulation factor XIII reduces systemic complications and improves the survival of mice after Streptococcus pyogenes M1 skin infection. Int J Med Microbiol 306(7):572–579. https://doi.org/10.1016/j.ijmm.2016.06.001 CrossRefPubMed

16.

Orosz ZZ, Katona É, Facskó A et al (2011) Factor XIII subunits in human tears; their highly elevated levels following penetrating keratoplasty. Clin Chim Acta 412(3–4):271–276. https://doi.org/10.1016/j.cca.2010.10.017 CrossRefPubMed

17.

Ariëns RA, Kohler HP, Mansfield MW et al (1999) Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscl Thromb Vasc Biol 19(8):2012–2016CrossRefPubMed

18.

Kopp A, Hebecker M, Svobodova E et al (2012) Factor H. A complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules 2(1):46–75. https://doi.org/10.3390/biom2010046 CrossRefPubMedPubMedCentral

19.

Rodriguez de Cordoba S, Rey-Campos J, Dykes DD et al (1988) Coagulation factor XIII B subunit is encoded by a gene linked to the regulator of complement activation (RCA) gene cluster in man. Immunogenetics 28(6):452–454CrossRef

20.

Fagerberg L, Hallström BM, Oksvold P et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Prot 13(2):397–406. https://doi.org/10.1074/mcp.M113.035600 CrossRef

21.

Simon Á, Bagoly Z, Hevessy Z et al (2012) Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia. Cytometry 82B(4):209–216. https://doi.org/10.1002/cyto.b.21019 CrossRef

22.

Thomas A, Gasque P, Vaudry D et al (2000) Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol 12(7):1015–1023CrossRefPubMed

23.

Okemefuna AI, Nan R, Gor J et al (2009) Electrostatic Interactions Contribute to the Folded-back Conformation of Wild Type Human Factor H. J Mol Biol 391(1):98–118. https://doi.org/10.1016/j.jmb.2009.06.010 CrossRefPubMed

24.

Aslam M, Perkins SJ (2001) Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J Mol Biol 309(5):1117–1138. https://doi.org/10.1006/jmbi.2001.4720 CrossRefPubMed

25.

Moore BL, Kelley LA, Barber J et al (2013) High-quality protein backbone reconstruction from alpha carbons using Gaussian mixture models. J Comput Chem 34(22):1881–1889. https://doi.org/10.1002/jcc.23330 CrossRefPubMed

26.

Xu D, Jaroszewski L, Li Z et al (2014) AIDA: ab initio domain assembly server. Nucleic Acids Res 42(W1):W308–W313. https://doi.org/10.1093/nar/gku369 CrossRefPubMedPubMedCentral

27.

Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA—a self-parameterizing force field. Proteins 47(3):393–402CrossRefPubMed

28.

Krieger E, Vriend G (2014) YASARA View: molecular graphics for all devices—from smartphones to workstations. Bioinformatics 30(20):2981–2982. https://doi.org/10.1093/bioinformatics/btu426 CrossRefPubMedPubMedCentral

29.

Katona E, Haramura G, Kárpáti L et al (2000) A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2). Thromb Haemost 83(2):268–273CrossRefPubMed

30.

Katona EE, Ajzner E, Toth K et al (2001) Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates. J Immunol Methods 258(1–2):127–135CrossRef

31.

Lee KN, Birckbichler PJ, Patterson MK, JR (1988) Colorimetric assay of blood coagulation factor XIII in plasma. Clin Chem 34(5):906–910PubMed

32.

Krushkal J, Bat O, Gigli I (2000) Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. Mol Biol Evol 17(11):1718–1730. https://doi.org/10.1093/oxfordjournals.molbev.a026270 CrossRefPubMed

33.

Reid KBM, Bentley DR, Campbell RD et al (1986) Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteins. Immunol Today 7(7–8):230–234. https://doi.org/10.1016/0167-5699(86)90110-6 CrossRefPubMed

34.

Müller-Calleja N, Ritter S, Hollerbach A et al (2018) Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies. Blood Adv 2(9):979–986. https://doi.org/10.1182/bloodadvances.2018017095 CrossRefPubMedPubMedCentral

35.

Skjeflo EW, Christiansen D, Fure H et al (2018) Staphylococcus aureus-induced complement activation promotes tissue factor-mediated coagulation. J Thromb Haemost 16(5):905–918. https://doi.org/10.1111/jth.13979 CrossRefPubMed

36.

Subramaniam S, Jurk K, Hobohm L et al (2017) Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 129(16):2291–2302. https://doi.org/10.1182/blood-2016-11-749879 CrossRefPubMedPubMedCentral

37.

Scheetz TE, Fingert JH, Wang K et al (2013) A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel loci. PLoS ONE 8(3):e58657. https://doi.org/10.1371/journal.pone.0058657 CrossRefPubMedPubMedCentral

38.

Hageman GS, Gehrs K, Lejnine S et al (2011) Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Human Genom 5(5):420–440CrossRef

39.

Schwartz ML, Pizzo SV, Hill RL et al (1973) Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem 248(4):1395–1407PubMed

Titel: Exploring the structural similarity yet functional distinction between coagulation factor XIII-B and complement factor H sushi domains
verfasst von: Mohammad Suhail Akhter
Sneha Singh
Hamideh Yadegari
Vytautas Ivaskevicius
Johannes Oldenburg
Arijit Biswas
Publikationsdatum: 26.03.2019
Verlag: Springer US
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 1/2019
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-019-01841-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin

Cefepime challenge after piperacillin/tazobactam-induced thrombocytopenia

A clinical practice-based evaluation of the RIETE score in predicting occult cancer in patients with venous thromboembolism

Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry

A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor